Greatmark Investment Partners Upped By $995,065 Its Gilead Sciences (GILD) Position, Shorts at Enerplus Resources Fund New (ERF) Raised By 42.08%

June 1, 2017 - By Dolores Ford

Greatmark Investment Partners Inc increased Gilead Sciences Inc (GILD) stake by 38.34% reported in 2016Q4 SEC filing. Greatmark Investment Partners Inc acquired 14,015 shares as Gilead Sciences Inc (GILD)’s stock declined 8.05%. The Greatmark Investment Partners Inc holds 50,565 shares with $3.62 million value, up from 36,550 last quarter. Gilead Sciences Inc now has $85.32 billion valuation. The stock rose 0.32% or $0.21 reaching $65.1 per share. About 16,807 shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since June 1, 2016 and is downtrending. It has underperformed by 38.50% the S&P500.

Enerplus Resources Fund New (NYSE:ERF) had an increase of 42.08% in short interest. ERF’s SI was 2.73M shares in June as released by FINRA. Its up 42.08% from 1.92 million shares previously. With 1.16 million avg volume, 2 days are for Enerplus Resources Fund New (NYSE:ERF)’s short sellers to cover ERF’s short positions. The SI to Enerplus Resources Fund New’s float is 1.2%. It closed at $7.89 lastly. It is down 69.92% since June 1, 2016 and is uptrending. It has outperformed by 53.22% the S&P500.

Investors sentiment decreased to 0.7 in Q4 2016. Its down 0.23, from 0.93 in 2016Q3. It is negative, as 106 investors sold GILD shares while 656 reduced holdings. 111 funds opened positions while 421 raised stakes. 950.84 million shares or 0.69% more from 944.29 million shares in 2016Q3 were reported. Sterling Capital Management Limited Co reported 1.06M shares. The California-based Ashfield Capital Partners Ltd Liability Corp has invested 0.44% in Gilead Sciences, Inc. (NASDAQ:GILD). Virtu Fincl Lc holds 0.04% or 5,121 shares in its portfolio. Hollencrest Secs Ltd Llc stated it has 0.04% in Gilead Sciences, Inc. (NASDAQ:GILD). Oregon Pub Employees Retirement Fund accumulated 1.01% or 678,725 shares. South State Corp reported 0.07% stake. Invsts Asset Mngmt Of Georgia Inc Ga Adv has 8,797 shares for 0.47% of their portfolio. Schwab Charles Inv Mngmt Inc holds 4.25 million shares or 0.33% of its portfolio. Platinum Invest Mngmt Ltd stated it has 1.33 million shares or 2.81% of all its holdings. Secor Cap Lp accumulated 35,197 shares. Cubic Asset Mgmt Ltd Llc holds 29,141 shares or 0.64% of its portfolio. Prudential Incorporated stated it has 0.4% in Gilead Sciences, Inc. (NASDAQ:GILD). Strategic Global Ltd Liability Co reported 1.22% stake. Klingenstein Fields & Llc accumulated 143,452 shares. 139,122 were accumulated by Thompson Siegel And Walmsley Ltd Llc.

Since December 1, 2016, it had 0 buys, and 9 sales for $28.57 million activity. MARTIN JOHN C sold $5.01 million worth of stock. WILSON GAYLE E also sold $1.41 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) on Thursday, February 23. Alton Gregg H had sold 5,000 shares worth $337,392 on Thursday, March 30. $668,667 worth of Gilead Sciences, Inc. (NASDAQ:GILD) was sold by Cogan John Francis on Tuesday, May 9.

Among 27 analysts covering Gilead Sciences (NASDAQ:GILD), 18 have Buy rating, 0 Sell and 9 Hold. Therefore 67% are positive. Gilead Sciences had 65 analyst reports since July 29, 2015 according to SRatingsIntel. Jefferies maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Tuesday, March 15. Jefferies has “Hold” rating and $97 target. The firm earned “Outperform” rating on Wednesday, November 2 by RBC Capital Markets. The company was maintained on Tuesday, May 30 by Maxim Group. The rating was maintained by Jefferies with “Buy” on Wednesday, October 5. Berenberg initiated it with “Buy” rating and $112 target in Monday, September 12 report. RBC Capital Markets maintained the stock with “Outperform” rating in Wednesday, July 29 report. The company was downgraded on Friday, October 2 by Morgan Stanley. The company was maintained on Tuesday, October 25 by Jefferies. Credit Suisse maintained the shares of GILD in report on Wednesday, September 14 with “Outperform” rating. Oppenheimer initiated Gilead Sciences, Inc. (NASDAQ:GILD) rating on Thursday, February 11. Oppenheimer has “Outperform” rating and $120 target.

Among 6 analysts covering Enerplus Corp (NYSE:ERF), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Enerplus Corp had 14 analyst reports since July 21, 2015 according to SRatingsIntel. Raymond James initiated the stock with “Outperform” rating in Friday, December 18 report. The firm has “Outperform” rating given on Friday, February 10 by BMO Capital Markets. The stock has “Neutral” rating by Macquarie Research on Friday, January 8. The stock of Enerplus Corp (USA) (NYSE:ERF) has “Buy” rating given on Monday, November 9 by UBS. The firm earned “Outperform” rating on Monday, November 9 by RBC Capital Markets. The firm has “Buy” rating given on Wednesday, August 17 by Canaccord Genuity. The stock has “Outperform” rating by Raymond James on Monday, June 6. FirstEnergy Capital upgraded Enerplus Corp (USA) (NYSE:ERF) on Monday, August 10 to “Market Perform” rating. The firm has “Outperform” rating by Macquarie Research given on Monday, June 6.

Enerplus Corporation is an oil and natural gas company. The company has market cap of $1.90 billion. The Company’s oil and natural gas property interests are located in the United States, primarily in North Dakota, Montana, and Pennsylvania, as well as in western Canada in the provinces of Alberta, British Columbia and Saskatchewan. It has a 4.52 P/E ratio. The Company’s oil and natural gas property interests contains proved plus probable gross reserves of approximately 14.3 million barrels of light and medium crude oil, 39.0 MMbbls of heavy crude oil, 123 MMbbls of tight oil, 18.1 MMbbls of natural gas liquids (NGLs), 126.3 billion cubic feet (Bcf) of conventional natural gas and 1,002.8 Bcf of shale gas, for a total of approximately 382.5 million barrels of oil equivalent (MMBOE).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts